Literature DB >> 17295647

Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.

Ying Guo1, Kennosuke Karube, Riko Kawano, Junji Suzumiya, Morishige Takeshita, Masahiro Kikuchi, Gao-Sheng Huang, Qing Li, Koichi Ohshima.   

Abstract

Bcl2 is an important protein involved in the pathogenesis of follicular lymphoma (FL). However, approximately 10% of FL cases do not express Bcl2. The present study was designed to compare gene aberrations, prosurvival gene expression, apoptosis and proliferation rates in Bcl2-positive and -negative FL cases. Bcl2 translocation and Bcl6 translocation were detected and compared using fluorescence in situ hybridization (FISH). A tendency for Bcl6 translocation to occur was found more frequently in Bcl2-negative FL than in the Bcl2-positive cases. The expression of Bcl-X, BAX, p53, Bcl6 was analyzed by immunohistochemistry. Bcl2 family proteins Bcl-X and BAX were expressed similarly in the two FL types. In some cases of Bcl2-negative FL there was high expression of Bcl6 or p53 but no such Bcl2-positive FL cases were detected. Furthermore, there was an inverse relationship between the expression of Bcl6 and p53. These results indicate that the Bcl6 translocation occurs more frequently in Bcl2-negative FL. Furthermore, other prosurvival proteins such as p53 and Bcl6 may play an important role in the pathogenesis of Bcl2-negative FL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17295647     DOI: 10.1111/j.1440-1827.2006.02072.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

Review 1.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

2.  Follicular lymphoma grade 3B: is it a real disease?

Authors:  Nancy Lee Harris; Philip Kluin
Journal:  Haematologica       Date:  2011-09       Impact factor: 9.941

3.  Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.

Authors:  E Leich; E Hoster; M Wartenberg; M Unterhalt; R Siebert; K Koch; W Klapper; M Engelhard; B Puppe; H Horn; A M Staiger; C Stuhlmann-Laeisz; H W Bernd; A C Feller; M Hummel; D Lenze; H Stein; S Hartmann; M L Hansmann; P Möller; W Hiddemann; M Dreyling; G Ott; A Rosenwald
Journal:  Leukemia       Date:  2015-12-01       Impact factor: 11.528

4.  Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components.

Authors:  Sheren F Younes; Andrew H Beck; Izidore S Lossos; Ronald Levy; Roger A Warnke; Yasodha Natkunam
Journal:  Am J Surg Pathol       Date:  2010-09       Impact factor: 6.394

5.  Altered expression of apoptotic genes in response to OCT4B1 suppression in human tumor cell lines.

Authors:  Mohammad Reza Mirzaei; Ali Najafi; Mohammad Kazemi Arababadi; Malek Hosein Asadi; Seyed Javad Mowla
Journal:  Tumour Biol       Date:  2014-07-11

6.  Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.

Authors:  Ellen Leich; Itziar Salaverria; Silvia Bea; Andreas Zettl; George Wright; Victor Moreno; Randy D Gascoyne; Wing-Chung Chan; Rita M Braziel; Lisa M Rimsza; Dennis D Weisenburger; Jan Delabie; Elaine S Jaffe; Andrew Lister; Jude Fitzgibbon; Louis M Staudt; Elena M Hartmann; Hans-Konrad Mueller-Hermelink; Elias Campo; German Ott; Andreas Rosenwald
Journal:  Blood       Date:  2009-05-26       Impact factor: 22.113

Review 7.  BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas.

Authors:  Magdalena Klanova; Pavel Klener
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.